alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2021035EN.01000101.xml

| 1.2.2021 | EN | Official Journal of the European Union | C 35/1 |
| --- | --- | --- | --- |

1.2.2021

EN

Official Journal of the European Union

C 35/1

---

Last publications of the Court of Justice of the European Union in the Official Journal of the European Union

(2021/C 35/01)

Last publication

OJ C 28, 25.1.2021

Past publications

OJ C 19, 18.1.2021

OJ C 9, 11.1.2021

OJ C 443, 21.12.2020

OJ C 433, 14.12.2020

OJ C 423, 7.12.2020

OJ C 414, 30.11.2020

These texts are available on:

EUR-Lex: http://eur-lex.europa.eu

---
Exhibit 32.2

CERTIFICATE PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, Paul R. Flanders, Chief Financial Officer of Carrols Corporation (the
Company), hereby certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Companys Quarterly Report on Form 10-Q for the period ended July 2, 2006, as filed with the Securities and Exchange Commission on the date hereof (the Annual
Report), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | --------------------------------------------------------------------------------------------------------------------------------------------------------------



|                                                      
|------------------------------------------------------
|/s/ PAUL R. FLANDERS                                  
|Paul R. Flanders                                      
|Vice President  Chief Financial Officer and Treasurer

August 16, 2006
Third Department,

March, 1963**

(March 13, 1963)

#### In the Matter of the Probate of the Will of Monroe L. Dix, Deceased. Rose Selby et al., Appellants; Chemical Bank New York Trust Company, as Temporary Administrator, et al., Respondents.

**

 Not published with other decisions of March 13, 1963, 18 A D 2d 1032.— [Rep.

Orders affirmed, with costs to all parties filing briefs payable from the estate. No opinion. Bergan, P. J., Herlihy and Reynolds, JJ., concur; Taylor, J., not voting.
Exhibit
      32.1








SECTION
      1350 CERTIFICATION OF


AMEREN
      CORPORATION


(required
      by Section 906 of the


Sarbanes-Oxley
      Act of 2002)








In
      connection with the report on Form 10-Q for the quarterly period ended June
      30, 2007 of Ameren Corporation (the “Registrant”) as filed by the
      Registrant with the Securities and Exchange Commission on the date hereof
      (the "Form 10-Q”), each undersigned officer of the Registrant does hereby
      certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the
      Sarbanes-Oxley Act of 2002, that:





(1)
            The
                Form 10-Q fully complies with the requirements of Section 13(a) or
                15(d)
                of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d));
                and





(2)
            The
                information contained in the Form 10-Q fairly presents, in all material
                respects, the financial condition and results of operations of the
                Registrant.










Date:  August 9,
      2007










/s/
      Gary L.
      Rainwater


Gary
      L.
      Rainwater


Chairman,
      President and Chief Executive Officer


(Principal
      Executive Officer)











/s/
      Warner L.
      Baxter


Warner
      L.
      Baxter


Executive
      Vice President and Chief Financial Officer


(Principal
      Financial Officer)
242.002 Interagency agreements. ( b ) ( i ) DoD requires reimbursement, at a rate set by the Under Secretary of Defense (Comptroller/Chief Financial Officer), from non-DoD organizations, except for— ( A ) Quality assurance, contract administration, and audit services provided under a no-charge reciprocal agreement;
( B ) Services performed under subcontracts awarded by the Small Business Administration under FAR subpart 19.8; and
( C ) Quality assurance requests performed for the Canadian Department of National Defence and pricing services performed for Public Works and Government Services Canada (PWGSC), operating as Public Services and Procurment Canada (PSPC).
( ii ) Departments and agencies may request an exception from the reimbursement policy in paragraph (b)(i) of this section from the Under Secretary of Defense (Comptroller/Chief Financial Officer). A request must show that an exception is in the best interest of the Government.
( iii ) Departments and agencies must pay for services performed by non-DoD activities, foreign governments, or international organizations, unless otherwise provided by reciprocal agreements. (S-70)(i) Foreign governments and international organizations may request contract administration services on their direct purchases from U.S. producers. Direct purchase is the purchase of defense supplies in the United States through commercial channels for use by the foreign government or international organization.
( ii ) PWGSC, operating as PSPC, is permitted to submit its requests for contract administration services directly to the cognizant contract administration office. ( iii ) Other foreign governments (including Canadian government organizations other than PSPC) and international organizations send their requests for contract administration services to the DoD Central Control Point (CCP) at the Headquarters, Defense Contract Management Agency, International and Federal Business Team. Contract administration offices provide services only upon request from the CCP. The CCP shall follow the procedures at PGI 242.002(S-70)(iii).
[64 FR 61029, Nov. 9, 1999, as amended at 65 FR 52952, Aug. 31, 2000; 65 FR 63804, Oct. 25, 2000; 70 FR 67920, Nov. 9, 2005; 83 FR 12681, Mar. 23, 2018]
#### In the Matter of Robert S. Persky, an Attorney.

Motion granted only to the extent of referring the matter to the Committee on Character and Fitness to hear and report as to respondent’s character and fitness to practice law in the State of New York and pending receipt of the report of said committee, final determination of the motion is held in abeyance. Concur—Murphy, P. J., Kupferman, Sandler, Sullivan and Lane, JJ.
#### 36.609 Contract clauses.
[Federal Register Volume 86, Number 26 (Wednesday, February 10, 2021)]
[Notices]
[Page 8916]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-02740]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Director, Strategic 
Business Initiatives Unit, Office of the Chief Operating Officer, CDC, 
pursuant to Public Law 92-463. The grant applications and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)-SIP21-006, Increasing Genetic 
Counseling Referrals Among Patients At-Risk for BRCA-Associated 
Cancers.
    Date: May 6, 2021.
    Time: 11:00 a.m.-6:00 p.m., EDT.
    Place: Teleconference.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Jaya Raman, Ph.D., Scientific 
Review Officer, National Center for Chronic Disease Prevention and 
Health Promotion, CDC, 4770 Buford Highway NE, Mailstop S107-8, 
Atlanta, Georgia 30341, Telephone: (770) 488-6511, <a href="/cdn-cgi/l/email-protection#034951626e626d436067602d646c75"><span class="__cf_email__" data-cfemail="c28890a3afa3ac82a1a6a1eca5adb4">[email protected]</span></a>.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-02740 Filed 2-9-21; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
IA 

118TH CONGRESS 

2D SESSION H. J. RES. 196 

Providing for congressional disapproval under chapter 8 of title 5, United 

States Code, of the rule submitted by the Department of Defense relating 

to ‘‘Defense Federal Acquisition Regulation Supplement: Architect and 

Engineering Service Fees (DFARS Case 2024–D019)’’. 

IN THE HOUSE OF REPRESENTATIVES 

AUGUST 2, 2024 

Mr. PALMER submitted the following joint resolution; which was referred to 

the Committee on Armed Services 

JOINT RESOLUTION 

Providing for congressional disapproval under chapter 8 of 

title 5, United States Code, of the rule submitted by 

the Department of Defense relating to ‘‘Defense Federal 

Acquisition Regulation Supplement: Architect and Engineering Service Fees (DFARS Case 2024–D019)’’. 

1 Resolved by the Senate and House of Representatives

2 of the United States of America in Congress assembled, 

3 That Congress disapproves the rule submitted by the De4 partment of Defense relating to ‘‘Defense Federal Acquisi5 tion Regulation Supplement: Architect and Engineering 

6 Service Fees (DFARS Case 2024–D019)’’ (89 Fed. Reg. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HJ 196 IH 

1 53502; published June 27, 2024) and such rule shall have 

2 no force or effect. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
Appropriations

| **Fiscal Year**       | **Amount** |
|-----------------------|------------|
| $35,200,000           |
| $49,200,000           |
| $51,700,000           |
| $51,364,000           |
| $51,060,952           |
| $50,652,512           |
| $50,146,470           |
| $0                    |
| $22,598,190           |
| $48,000,000           |
| $48,000,000           |
| $46,846,120           |
| $43,917,000           |
| $41,630,000           |
| $41,630,000           |
| $41,630,000           |
| $41,630,000           |
| $41,630,000 (Request) |
|                  |
#### The People of the State of New York, Respondent, v Alvin Lewis, Appellant.

Appeal by defendant from a judgment of the County Court, Westchester County, rendered February 17, 1977, convicting him of criminal sale of a controlled substance in the fifth degree, upon his plea of guilty, and imposing sentence. The appeal also brings up for review an order of the same court, dated September 21, 1976, which denied, without a hearing, defendant’s motion to dismiss the indictment on the ground of prejudicial delay. By order dated February 6, 1978, this court remanded the case to the County Court for a hearing and a new determination on defendant’s motion to dismiss the indictment and directed that the appeal be held in abeyance in the interim *(People v Lewis,*61 AD2d 799). The court has now complied and rendered a decision in accordance therewith. Judgment affirmed. No opinion. Martuscello, 3. P., Rabin, Cohalan and Hawkins, JJ., concur.
----

----

|   Cleco                  Corporation                                  |
|---------------------------------------------------------------------------------|
| CERTIFICATION                  PURSUANT TO                                      |
| 18                  U.S.C. SECTION 1350,                                        |
| AS                  ADOPTED PURSUANT TO                                         |
| SECTION                  906 OF THE SARBANES-OXLEY ACT OF                  2002 |

| (1)                  The Report fully complies with the requirements of Section 13(a)                  or 15(d)                  of the Securities Exchange Act of 1934;                                                                 |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (2)                  The information contained in the Report fairly presents, in all                  material                  respects, the financial condition and results of operations of                  the                  Company. |

| /s/                  Michael H. Madison                                                                                 |
|-------------------------------------------------------------------------------------------------------------------------|
| Michael                  H. Madison                    President and Chief Executive                  Officer |

| /s/                  Kathleen F. Nolen                                                                                                          |
|-------------------------------------------------------------------------------------------------------------------------------------------------|
| Kathleen                  F. Nolen                    Senior Vice President and                     Chief Financial Officer |

----

----
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.J. Res. 191 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
H. J. RES. 191

  Providing for congressional disapproval under chapter 8 of title 5, 
 United States Code, of the rule submitted by the Department of Energy 
       relating to ``Loan Guarantees for Clean Energy Projects''.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             July 18, 2024

Mr. Palmer submitted the following joint resolution; which was referred 
    to the Committee on Energy and Commerce, and in addition to the 
    Committee on Science, Space, and Technology, for a period to be 
subsequently determined by the Speaker, in each case for consideration 
  of such provisions as fall within the jurisdiction of the committee 
                               concerned

_______________________________________________________________________

                            JOINT RESOLUTION

 
  Providing for congressional disapproval under chapter 8 of title 5, 
 United States Code, of the rule submitted by the Department of Energy 
       relating to ``Loan Guarantees for Clean Energy Projects''.

    Resolved by the Senate and House of Representatives of the United 
States of America in Congress assembled, That Congress disapproves the 
rule submitted by the Department of Energy relating to ``Loan 
Guarantees for Clean Energy Projects'' (88 Fed. Reg. 34419 (May 30, 
2023)), and such rule shall have no force or effect.
                                 <all>
```
CONFIDENTIAL
CONFIDENTIAL
CONFIDENTIAL
CONFIDENTIAL
CONFIDENTIAL
CONFIDENTIAL
CONFIDENTIAL
CONFIDENTIAL
CONFIDENTIAL
CONFIDENTIAL
#### Christie’s (International) S. A., Respondent, v Adrian Gugliarda, Appellant.

— Motion for resettlement of the order of this court entered on November 16, 1978 [65 AD2d 714] granted so as to add the following sentence to the decretal paragraph thereof: "The judgment entered thereon on June 13, 1978 in Supreme Court, New York County, is vacated.” Resettled order signed and filed. Concur — Birns, J. P., Evans, Fein, Lane and Silverman, JJ.
UNITED STATES DISTRICT COURT

FOR THE Northern District of Illinois − CM/ECF LIVE, Ver 6,1

Eastern Division

Jeffrey Satterfield, et al.

Plaintiff,

v. Case No.: 1:12−cv−05704

Honorable Sara L. Ellis

Lime Energy Co., et al.

Defendant.

NOTIFICATION OF DOCKET ENTRY

This docket entry was made by the Clerk on Tuesday, January 28, 2014:

 MINUTE entry before the Honorable Daniel G. Martin: Status hearing held.

Parties have reached an agreement. All matters relating to the referral of this action having

been concluded, the referral is closed and the case is returned to the assigned judge.

Mailed notice(lxs, )

ATTENTION: This notice is being sent pursuant to Rule 77(d) of the Federal Rules of

Civil Procedure or Rule 49(c) of the Federal Rules of Criminal Procedure. It was

generated by CM/ECF, the automated docketing system used to maintain the civil and

criminal dockets of this District. If a minute order or other document is enclosed, please

refer to it for additional information.

For scheduled events, motion practices, recent opinions and other information, visit our

web site at www.ilnd.uscourts.gov.

Case: 1:12-cv-05704 Document #: 99 Filed: 01/28/14 Page 1 of 1 PageID #:909
#### 403.602 Exceptions.

The HCA is authorized to accept a contract from the policy in FAR 3.601.
EXHIBIT 32.1
                                                                    ------------


CERTIFICATION OF PERIODIC REPORT

I, Charles W. Fischer, President and Chief Executive Officer of Nexen Inc., a
Canadian Corporation (the "Company"), certify, pursuant to 18 U.S.C. Section
1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

    (1)    the Quarterly Report on Form 10-Q of the Company for the quarterly
           period ended September 30, 2004 as filed with the Securities and
           Exchange Commission on the date hereof (the "Report") fully complies
           with the requirements of Section 13(a) or 15(d) of the Securities
           Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

    (2)    the information contained in the Report fairly presents, in all
           material respects, the financial condition and results of operations
           of the Company.



Date:  October 18, 2004                    /s/ Charles W. Fischer
                                           ------------------------------
                                           Charles W. Fischer
                                           President and Chief Executive Officer


A signed original of this written statement required by Section 906 has been
provided to Nexen Inc. and shall be retained by Nexen Inc. and furnished to the
Securities and Exchange Commission or its staff upon request.
Page:1 of 3 COST MODEL ANALYSIS TEMPLATE

Light-Duty Technology Cost Study

EP-C-07-069 WA1-3

Printed: 8/13/2012

DRAFT

Material Labor Burden End Item 

Scrap SG&A Profit ED&T-R&D Material Labor

USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD

13 Info, Gage and Warning System

1 01 Instrument Cluster Subsystem 1.70 0.05 0.31 2.07 0.01 0.12 0.14 0.07 0.34 0 2.41 - - - 1.95 0.06

SUBSYSTEM ROLL-UP 1.70 0.05 0.31 2.07 0.01 0.12 0.14 0.07 0.34 0 2.41 - - - 1.95 0.06

Investment

(X1000)

SYSTEM & SUBSYSTEM DESCRIPTION NEW TECHNOLOGY GENERAL PART INFORMATION

Manufacturing Total 

Manufacturing 

Cost 

(Component/ 

Assembly)

Tooling 

(x1000)

Markup

Total Markup 

Cost 

(Component/ 

Assembly)

Item

System

Subsystem

System 

ED&T/R&D

(x1000)

Sub-Subsystem Description

Manufacturing 

Net 

Component/ 

Assembly Cost 

Impact to OEM

Total 

Packaging 

Cost 

(Component/ 

Assembly)

Technology Level: Toyota Venza Mass-Reduction and Cost Analysis

Vehicle Class: Small & Mid Size Cross-Over Passenger Vehicle

Study Case#: 07-069-303LW

09000064810d3b0c.xls

EPA Contract:EP-C-07-069 WA1-3 PROPRIETARY and CONFIDENTIAL

Author: G. Kolwich

(248)373-6000 Ext. 2411
Page:2 of 3 COST MODEL ANALYSIS TEMPLATE

Light-Duty Technology Cost Study

EP-C-07-069 WA1-3

Printed: 8/13/2012

DRAFT

13 Info, Gage and Warning System

1 01

Item

System

Subsystem

Burden End Item 

Scrap SG&A Profit ED&T-R&D Material Labor Burden End Item Scrap SG&A Profit ED&T-R&D

USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD

 0.22 2.23 0.01 0.13 0.15 0.07 0.37 0 2.60 - - - 0.25 0.01 (0.09) 0.16 0.00 0.01 0.01 0.01 0.03 0 0.19

 0.22 2.23 0.01 0.13 0.15 0.07 0.37 0 2.60 - - - 0.25 0.01 (0.09) 0.16 0.00 0.01 0.01 0.01 0.03 0 0.19

BASE TECHNOLOGY GENERAL PART INFORMATION INCREMENTAL COST TO UPGRADE TO NEW TECHNOLOGY PACKAGE

System 

ED&T/R&D

(x1000)

Tooling 

(x1000)

Investment

(X1000)

Manufacturing 

Total Markup 

Cost 

(Component/ 

Assembly)

Total 

Packaging 

Cost 

(Component/ 

Assembly)

Net 

Component/ 

Assembly Cost 

Impact to OEM

Total 

Manufacturing 

Cost 

(Component/ 

Assembly)

Total 

Manufacturing 

Cost 

(Component/ 

Assembly)

Markup Markup

Total Markup 

Cost 

(Component/ 

Assembly)

Total 

Packaging 

Cost 

(Component/ 

Assembly)

Net 

Component/ 

Assembly Cost 

Impact to OEM

09000064810d3b0c.xls

EPA Contract:EP-C-07-069 WA1-3 PROPRIETARY and CONFIDENTIAL

Author: G. Kolwich

(248)373-6000 Ext. 2411
Page:3 of 3 COST MODEL ANALYSIS TEMPLATE

Light-Duty Technology Cost Study

EP-C-07-069 WA1-3

Printed: 8/13/2012

DRAFT

13 Info, Gage and Warning System

1 01

Item

System

Subsystem

USD USD USD

 - - -

 - - -

System 

ED&T/R&D

(x1000)

W TECHNOLOGY PACKAGE

Tooling 

(x1000)

Investment 

(X1000)

09000064810d3b0c.xls

EPA Contract:EP-C-07-069 WA1-3 PROPRIETARY and CONFIDENTIAL

Author: G. Kolwich

(248)373-6000 Ext. 2411